top of page

Advancing Vaccine Innovation & Diagnostics

Innovative solutions for infectious diseases and neurodegenerative disorders.

Our Mission

Developing new efficacious universal protein subunit vaccines for infectious agents that are a major public health concern worldwide, and novel diagnostics for both infectious and neurodegenerative diseases.

Our Focus Areas

Targeting Global Diarrheal Diseases
 

We are focused on developing innovative vaccines that combat human diarrheal pathogens, which remain one of the leading causes of illness and mortality, particularly in developing regions.​​​​​​​​​​​

Vaccines for Biothreat and Veterinary Infectious Agents
 

We are at the forefront of developing vaccines that address both biothreat agents and veterinary infectious diseases. Our efforts focus on pathogens that pose a significant threat to public health and security, including those with potential for bioterrorism.

Innovating Solutions for Neurodegenerative Disorders
 

Our focus on neurodegenerative diseases such as Parkinson’s Disease (PD) and Alzheimer’s Disease (AD) aims to uncover novel biomarkers for development of new diagnostics and therapeutics to slow or halt disease progression.​​​​​​

Our Revolutionary
Technology

Our proprietary Proteomics-based Expression Library Screening (PELS) technology for protein-antigen discovery was developed at Massachusetts General Hospital / Harvard Medical School by our founder.

Partner with PathoVacs for Biomedical Breakthroughs

PathoVacs is seeking collaborations for commercialization of our current vaccine targets .  In addition, PathoVacs provides contract protein biomarker discovery services for a broad array of pathogens. 

bottom of page